India could soon have another locally developed vaccine as the deadly Covid crisis shows no signs of slowing

Drugmaker Cadila Healthcare, which is also known as Zydus Cadila, is conducting phase three clinical trials on 28,000 people.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.